Skip to main content

Dr. Hannah Levavi

Hematology & Oncology (Hematology & Oncology Physician)

  • Medicare participating

At a glance

Years since graduation
10
In the NPI registry since
2016
Medicare patients seen, 2024
54

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2016Registered with an NPI (national billing number; not a license date)

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Hematology & Oncology Physician primary
    NY license 297428

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Hematology & Oncology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
54
Services billed
251
Patients’ average age
75
Most frequent Medicare services, 2023
ServiceTimesPatients
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes6615
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes1211

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Most prescribed drugs, Medicare Part D 2024
DrugPrescriptions
Levofloxacin
Other prescribers in New York, NY
11

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 10 companies reported 26 payments worth $3,397 in total to this clinician.

By company
Takeda Pharmaceuticals U.S.A., Inc.$2,364
Daiichi Sankyo Inc.$290
Amgen Inc.$173
Sobi, Inc$163
Kite Pharma, Inc.$151
Celgene Corporation$81.57
Blueprint Medicines Corporation$61.75
Genzyme Corporation$54.75
By type
Consulting Fee$1,875
Food and Beverage$1,207
Travel and Lodging$315

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Jan 10, 2025Takeda Pharmaceuticals U.S.A., Inc.
Jan 10, 2025
Consulting Fee
ICLUSIG · ONCOLOGY
$1,875
Jan 10, 2025Takeda Pharmaceuticals U.S.A., Inc.
Jan 10, 2025
Travel and Lodging
ICLUSIG · ONCOLOGY · travel to SAN DIEGO, CA · in-kind
$255
Jan 10, 2025Takeda Pharmaceuticals U.S.A., Inc.
Jan 10, 2025
Travel and Lodging
ICLUSIG · ONCOLOGY · travel to SAN DIEGO, CA · in-kind
$60.26

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in New York →

Other Hematology & Oncology clinicians in New York

Sources

NPI registry (CMS NPPES, November 2026; record last updated August 4, 2023), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1376906776. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.